Open AccessPharmacologic doses of recombinant human erythropoietin in the treatment of myelodysplastic syndromes [see comments]
Author(s) -
R S Stein,
RI Abels,
SB Krantz
Publication year - 1991
Publication title -
blood
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 5.515
H-Index - 465
eISSN - 1528-0020
pISSN - 0006-4971
DOI - 10.1182/blood.v78.7.1658.1658
Subject(s) - medicine , erythropoietin , hematocrit , myelodysplastic syndromes , anemia , placebo , toxicity , granulocyte colony stimulating factor , clinical trial , erythropoiesis , refractory (planetary science) , gastroenterology , surgery , chemotherapy , bone marrow , pathology , physics , alternative medicine , astrobiology
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom